Vaccination for neonates is a critical component of public health efforts to protect infants from serious infectious diseases. The recommended vaccines for neonates typically include hepatitis B vaccine, administered shortly after birth to prevent perinatal transmission of the virus. Vaccination schedules may vary by country, but common immunizations for neonates often target diseases such as tuberculosis, diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (Hib). These vaccines aim to establish early immunity in vulnerable newborns, offering protection against potentially life-threatening infections. The immune system of neonates is still developing, making timely vaccination essential for safeguarding their health. Vaccination efforts also contribute to herd immunity, protecting those who cannot receive vaccines due to medical reasons. Pediatricians and healthcare providers play a crucial role in educating parents about the importance of following the recommended vaccine schedule for neonates. Ongoing research continues to refine and expand vaccine options for neonatal immunization, ensuring comprehensive protection against preventable diseases during the vulnerable early stages of life.
Submit your abstract Today
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan